Ojectives: To explore the effect of STAT3 pathway on the autophagy of human glomerular mesangial cells (HGMC) and expression of extracellular matrix Collagen IV cultured in high glucose.
Objective: Autophagy plays an important role in maintaining podocytes homeostasis. Reduced autophagy may result in limited renal cell function during exposure to high glucose. In this study, we investigated the effects of ursolic acid (UA) on autophagy and podocytes injury induced by high glucose.
Methods: Conditionally immortalized murine podocytes were cultured in media containing high glucose, and we determined the effect of the PI3K inhibitor LY294002 and ursolic acid treatment on protein expression. miR-21 expression was detected using RT-qPCR. Activation of the PTEN-PI3K/Akt/mTOR pathway, expression of autophagy-associated proteins and expression of podocytes specific proteins were determined by Western blot. Immunofluorescence was used to monitor expression of podocytes specific proteins and LC3 accumulation. Autophagosomes were observed using electron microscopy. Results: During exposure to high glucose condition, autophagy was reduced in podocytes. Increased miR-21 expression, decreased PTEN expression, and activation of the PI3K/Akt/mTOR pathway were observed during exposure to high glucose. Ursolic acid and LY294002 reduced podocytes injury through autophagy rescue. Our data suggest ursolic acid inhibits miR-21 expression and increases PTEN expression, thereby inhibiting Akt and mTOR and restoring autophagy levels. Conclusion: Our data suggest that podocytes injury is associated with reduced autophagy levels during exposure to high glucose. Ursolic acid reduces podocytes injury by increasing autophagy through miR-21 inhibition and PTEN expression. Objective: To observe the influence of Shenkang injection on renal artery peak velocity in systole (Vs) and resistance indices (RI) of patients with early diabetic nephropathy. Methods: A total of 58 early diabetic nephropathy patients were randomly divided into conventional treatment group (A group) and Shenkang Injection-treated group (B group), 29 cases in each group. To detect the level of UAER between before and after treatment, color Doppler ultrasound were used to cheek and analyze the chief renal arteries and intersegmental arteries Vs and RI of patients. Moreover, 25 healthy subjects were measured for control. Results: (1) Vs of patients with early diabetic nephropathy was significantly lower than that in normal control group, RI was significantly higher than that in normal control group (P < 0.01).
(2) Vs of B group was significantly higher than that before (P < 0.01), and RI was significantly lower than that before (P < 0.05). All the improvements were better than those in A group. The A group had no significant difference with treated before (P > 0.05). UAER of B group was significantly lower than that before and better than that of A group (p < 0.01). Conclusion: Shenkang injection can increase renal artery peak velocity in systole, decrease resistance indices, improve renal ischemia state, decrease urine protein, and has curative effect on diabetic nephropathy in earlier stage. Objective: To observe the effect of glucagon like peptide-1 receptor agonist liraglutide on blood pressure and water-sodium metabolism in rats High glucose inhibits autophagy activity and induces STAT3 activation of human glomerular mesangial cells at 24 h. Objective: Compare the efficacy and safety of anticoagulation with different doses of heparin in the continuous renal replacement therapy (CRRT) for diabetic nephropathy, confirm the effective dose of anticoagulant in the treatment of CRRT for diabetic nephropathy to provide the basic data for clinical work.
Methods: 54 patients with diabetic nephropathy were randomly divided into three groups; group 1 (18 patients, heparin, 0.3 mg/kg), group 2 (18 patients, heparin, 0.4 mg/kg), group 3 (18 patients, heparin, 0.5 mg/kg). To evaluate coagulation function, the filter and pipeline were observed; the activated partial thromboplastin time (APTT) and platelet levels were monitored before or after treatment. Results: In group 1, the APTT and platelet levels had no significant change after treatment; in group 2, the APTT extended to 1.5 times with no significant change of platelet levels; in group 3, the APTT raised obviously, otherwise, the platelet levels decreased remarkable with significance among group 1, group 2 and group 3 (P < 0.05). Objective: To investigate the effect of irbesartan in regulating the expression of PINCH-1 in the kidney tissue of diabetes mellitus rat using diabetes mellitus rat model. Methods: After establishing rat model of diabetes mellitus, real-time polymerase chain reaction (RT-PCR) and Western blot were applied to detect the expression of PINC-1 in the kidney tissue of diabetes mellitus rat after irbesartan treatment.
Results: RT-PCR shown the PINCH-1 mRNA expression in diabetes mellitus rat (1.537 AE 0.04) was higher than in the normal rat (1.128 AE 0.03), and decreased after the treatment of irbesartan (1.246 AE 0.02) (P < 0.05). Western blot showed the expression of PINCH-1 in the kidney tissue of diabetes mellitus rat with irbesartan treatment (1.159 AE 0.03) (P > 0.05). 
